| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.51 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.08 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |